Bridget Corcoran

Certis Oncology is transforming how oncology R&D decisions are made. Through Certis Oncology Intelligence®, our AI-powered translational decision intelligence platform, we help biopharma organizations generate data-driven insights into therapeutic response, identify biomarkers, prioritize experiments, and accelerate drug development. Traditional drug development generates vast amounts of scientific data, yet much of that knowledge remains fragmented across studies, teams, and systems. Certis Oncology Intelligence® is designed to help organizations unlock the full value of those data assets by integrating predictive intelligence, agentic data exploration, and experimental validation into a unified decision intelligence ecosystem. The platform combines: • CertisAI™ — a predictive intelligence engine that leverages relationships between drug chemistry and tumor biology to generate insights into therapeutic response • Agentic Data Ecosystems — secure, sponsor-specific environments that transform fragmented scientific data into actionable knowledge • Experimental Validation — patient-derived models and translational research capabilities that enable functional validation of AI-generated insights Together, these capabilities help researchers move beyond isolated datasets and disconnected workflows toward a more intelligent, data-driven approach to oncology research and development. Our mission is simple: help researchers make better decisions, faster, and ultimately improve outcomes for patients facing cancer.